Misplaced Pages

ASP2535

Names
IUPAC name 4--2,1,3-benzoxadiazole
Identifiers
CAS Number	374886-51-8
3D model (JSmol)	Interactive image
ChEMBL	ChEMBL4303475
PubChem CID	9800113
UNII	6627LI8F9K
InChI InChI=1S/C22H18N6O/c1-14(2)21-24-25-22(28(21)19-10-6-9-18-20(19)27-29-26-18)16-11-12-17(23-13-16)15-7-4-3-5-8-15/h3-14H,1-2H3Key: FQGLDGKVKDPVLO-UHFFFAOYSA-N
SMILES CC(C)C1=NN=C(N1C2=CC=CC3=NON=C32)C4=CN=C(C=C4)C5=CC=CC=C5
Properties
Chemical formula	C22H18N6O
Molar mass	382.427 g·mol
Except where otherwise noted, data are given for materials in their standard state (at 25 °C , 100 kPa). Infobox references

ASP2535 is an inhibitor of the type 1 glycine transporter. It could potentially be used in treatment of Alzheimer's disease and schizophrenia.

Potential uses

ASP2535 has been investigated for the treatment of Alzheimer's disease and schizophrenia, it is able to inhibit the memory deficit induced by scopolamine, an anticholinergic agent.

References

1. ^ Harada, Katsuya; Nakato, Kazuhiro; Yarimizu, Junko; Yamazaki, Mayako; Morita, Masahiko; Takahashi, Shinji; Aota, Masaki; Saita, Kyoko; Doihara, Hitoshi; Sato, Yuichiro; Yamaji, Takayuki; Ni, Keni; Matsuoka, Nobuya (2012-06-15). "A novel glycine transporter-1 (GlyT1) inhibitor, ASP2535 (4-[3-isopropyl-5-(6-phenyl-3-pyridyl)-4H-1,2,4-triazol-4-yl]-2,1,3-benzoxadiazole), improves cognition in animal models of cognitive impairment in schizophrenia and Alzheimer's disease". European Journal of Pharmacology. 685 (1–3): 59–69. doi:10.1016/j.ejphar.2012.04.013. ISSN 1879-0712. PMID 22542656.

This pharmacology-related article is a stub. You can help Misplaced Pages by expanding it.

• v
• t
• e

This article about a biochemical receptor is a stub. You can help Misplaced Pages by expanding it.

• v
• t
• e

• Pharmacology stubs
• Receptor stubs
• Pyridines
• Benzoxadiazoles
• Triazoles
• Isopropyl compounds
• Phenyl compounds